Veriheal

MAY 2, 2023

Among his many contributions was the first ever isolation of tetrahydrocannabinol (THC) — cannabis’ primary psychoactive cannabinoid. I believe cannabinoids represent a medical treasure waiting to be discovered,” is one of his most famous (and still relevant) quotes.

Research and Development 96

Research and Development Epilepsy Cannabinoids Medicine 96

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JANUARY 28, 2020

The different approaches on the legality of cultivation and use of (medical) cannabis in the member states have led to a policy paradox within the European Union, causing complications for patients in several member states.

Medicine 59

Medicine Cultivation Research and Development Policy 59

Veriheal

OCTOBER 1, 2020

Amphetamines, barbiturates, cannabis, codeine, ketamine, methylphenidate (Ritalin), synthetic cannabinoids, synthetic cathinones (for example mephedrone, methoxetamine). The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy.

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52